Financials
Financial year 2025
FEBRIS BIORISK CONSULT from Aalter, company number BE0649484581, closed financial year 2025 with a result of € 97,386 after tax. For that financial year FEBRIS BIORISK CONSULT recorded a gross margin of € 128,264 and equity of € 512,715. Compared with financial year 2024, the result moved from € 102,882 to € 97,386. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 512,715
▲ 23% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 97,386
▼ 5% vs 2024
Profit after tax over the fiscal year.
€ 472,664
▲ € 386,736 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 494,115.
People and assets in 2025
€ 12,946
▼ 42% vs 2024
Of which on lease € 12,946.
Debts at end 2025
€ 13,029
▼ 42% vs 2024
€ 9,733 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 1,977
▼ 24% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,128
▼ 71% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 133,494 | € 183,454 | € 145,069 | € 128,264 | ▼ 12% |
| Profit after taxes | € 96,566 | € 120,916 | € 102,882 | € 97,386 | ▼ 5% |
| Equity | € 236,531 | € 357,447 | € 415,329 | € 512,715 | ▲ 23% |
| Total debts | € 98,225 | € 69,577 | € 108,510 | € 32,485 | ▼ 70% |
| Cash | € 223,070 | € 47,307 | € 85,928 | € 472,664 | ▲ € 386,736 |
| Retained profit | € 217,931 | € 338,847 | € 396,729 | € 494,115 | ▲ 25% |
| Dividend | € 36,000 | € 0 | € 45,000 | € 0 | ▼ 100% |
| Bank debt | € 7,368 | € 31,812 | € 22,532 | € 13,029 | ▼ 42% |
| Balance sheet total | € 334,755 | € 427,024 | € 523,839 | € 545,200 | ▲ 4% |
Key figures of FEBRIS BIORISK CONSULT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to FEBRIS BIORISK CONSULT?
What happened at FEBRIS BIORISK CONSULT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 97,386 (▼ 5% vs 2024). Source: NBB ↗
- New establishment in Aalter. KBO
- Start of the company according to the CBE. KBO
In short
From € 96,566 profit in 2022 to € 97,386 profit in 2025.
Paid € 149,598 in corporate taxes since 2022.
Best year ever: 2023, with € 120,916 profit.
Paid out € 81,000 in dividends to the owners in total.
Management
Behind FEBRIS BIORISK CONSULT is Antoine De Kesel.
Directors
According to the 2025 annual accounts
Antoine De Kesel
Director
Establishments
Establishment units
Physical locations of this company
Imkerstraat 8
9880 Aalter
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Domain
Domain
febrisbiorisk.com
Registered
2016-03-21
Registrar
Nomeo BV
Expires
2026-03-21
Website info
Features
Security
Network
Details
- Company number
- 0649.484.581
- VAT number
- BE 0649.484.581
- Registered office
- Imkerstraat 8, 9880 Aalter
- Names & denominations
- FEBRIS BIORISK CONSULT
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 February 2016
- Peppol
- Active · Active since 13 Nov 2025
- Contact
- febrisbiorisk.com +32-9-225-80-91
- Activities · NACE
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Overige vormen van onderwijs
Activiteiten van holdings
Literaire creatie
Holdings
Scheppende kunsten, m.u.v. ondersteunende diensten